Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
Elemento
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicaciónTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Título
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
Materia
Descripción
The renin–angiotensin–aldosterone system (RAAS) is an elegant cascade of vasoactive peptides that orchestrate key processes in human physiology.
Fecha
2020-04-23
Tipo
Citación
Vaduganathan, Muthiah, Orly Vardeny, Thomas Michel, John J. V. McMurray, Marc A. Pfeffer, and Scott D. Solomon. 2020. "Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19." New England Journal of Medicine 382 (17):1653-9.
Accesibilidad
Free online on NEJM.
Was this resource helpful?